Yesterday’s approval of Vertex’s Pharmaceutical Inc.’s hepatitis C treatment triggers one the biggest real estate deals in Boston’s history and is expected to spur the economic turnaround of the waterfront’s industrial area.
Construction of two buildings totaling more than a million square feet and costing about $800 million is scheduled to begin on Fan Pier as soon as this week and be completed in 2013 or 2014.
City and business leaders say the arrival of the biotechnology company, which plans to move its headquarters and about 1,500 employees from Cambridge, will attract similar businesses to the area.
